LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Ultraspeed Resolution Reveals that Ubiquitins Bind Sequentially

By LabMedica International staff writers
Posted on 15 Dec 2009
Print article
An innovative reaction quenching protocol with millisecond resolution has revealed that cells attach ubiquitin chains to proteins marked for destruction link by link rather than all at once.

The addition of a chain of four or more ubiquitin molecules to a target protein marks that protein for destruction by protein-degrading complexes in the cell. Heretofore, it was not known whether these molecules were added to the target protein sequentially or as a pre-formed chain.

In the current study, investigators at California Institute of Technology (Pasadena, USA) developed new methodology to study the action of ubiquitin ligase, the enzyme complex that attaches ubiquitin to the target protein at short time intervals that had not previously been possible. For this purpose, they adapted an instrument called a "quench-flow" machine, a machine that allows for extreme precision in the stopping, or "quenching," of a reaction. This instrument allowed them to follow changes in structure at intervals as short as 10 milliseconds in both yeast and human proteins.

"We devised methods to take snapshots of ubiquitin ligase reactions at a rate of up to 100 "pictures" every second," said senior author Dr. Raymond Deshaies, professor of biology at the California Institute of Technology. "This enables us to see things that would normally evade detection. Prior methods did not have sufficient time resolution to see what was going on. It is as if you gave an ice-cream cone to a kid and took pictures every minute. You would see the ice cream disappear from the first photo to the next, but since the pictures are too far apart in time, you would have no idea whether the child ate the ice cream one bite at a time, or swallowed the entire scoop in one gulp."

Results published in the December 3, 2009, issue of the journal Nature revealed that the three ubiquitin ligase enzymes, E1, E2, and E3 work as a team to build polyubiquitin chains on substrates by sequential transfers of single ubiquitins.

"The new method revealed the biological equivalent of small, single bites of ice cream," said Dr. Deshaies. "Using our approach we could see that our ubiquitin ligase builds ubiquitin chains one ubiquitin at a time. Gaining these kinds of insights into the ubiquitin system is important because ubiquitin ligases play a critical role in a number of human diseases, including cancer, due to their role in the regulation of the cell cycle."

Related Links:
California Institute of Technology


Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
H.pylori Test
Humasis H.pylori Card
New
Centromere B Assay
Centromere B Test

Print article

Channels

Molecular Diagnostics

view channel
Image: The study investigated D-dimer testing in patients who are at higher risk of pulmonary embolism (Photo courtesy of Adobe Stock)

D-Dimer Testing Can Identify Patients at Higher Risk of Pulmonary Embolism

Pulmonary embolism (PE) is a commonly suspected condition in emergency departments (EDs) and can be life-threatening if not diagnosed correctly. Achieving an accurate diagnosis is vital for providing effective... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Sekisui Diagnostics UK Ltd.